Peter Daniel
Oncology
Max Delbruck Center for Molecular Medicine in the Helmholtz Association
Germany
Biography
Dr. Daniel Olal is currently working as a scientist in the Department of Oncology, Max Delbruck Center for Molecular Medicine in the Helmholtz Association , Germany. His research interests includes Clinical & Molecular Oncology. He is serving as an editorial member and reviewer of several international reputed journals. Dr. Daniel Olal is the member of many international affiliations. He has successfully completed his Administrative responsibilities. He has authored of many research articles/books related to Clinical & Molecular Oncology.
Research Interest
Clinical & Molecular Oncology
Publications
-
Daniel PT, Koert U, Schuppan J. (2006). Apoptolidin: induction of apoptosis by a natural product. Angew Chem Int Ed Engl. 45, 872-93.
-
Hemmati, PG, Güner D, Gillissen B, Wendt J, von Haefen C, Chinnadurai G, Dörken B, Daniel PT. (2006). Bak functionally complements for loss of Bax during p14ARF-induced mitochondrial apoptosis in human cancer cells. Oncogene. 25, 6582-94.
-
Gillissen B, Essmann F, Hemmati P, Richter A, Richter A, Öztop I,Chinnadurai G, Dörken B and Daniel PT.(2007). Mcl-1 mediates the Bax dependency of Nbk/Bik-induced apoptosis. J Cell Biol. 179, 701-715.
